ITMI20031098A0 - Composti utili nella terapia del morbo di alzheimer e formulazioni che li contengono - Google Patents

Composti utili nella terapia del morbo di alzheimer e formulazioni che li contengono

Info

Publication number
ITMI20031098A0
ITMI20031098A0 IT2003MI001098A ITMI20031098A ITMI20031098A0 IT MI20031098 A0 ITMI20031098 A0 IT MI20031098A0 IT 2003MI001098 A IT2003MI001098 A IT 2003MI001098A IT MI20031098 A ITMI20031098 A IT MI20031098A IT MI20031098 A0 ITMI20031098 A0 IT MI20031098A0
Authority
IT
Italy
Prior art keywords
alzheimer
formulations
therapy
disease
contain
Prior art date
Application number
IT2003MI001098A
Other languages
English (en)
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Priority to IT001098A priority Critical patent/ITMI20031098A1/it
Publication of ITMI20031098A0 publication Critical patent/ITMI20031098A0/it
Priority to PCT/EP2004/005644 priority patent/WO2004106275A2/en
Priority to BRPI0410703-9A priority patent/BRPI0410703A/pt
Priority to AU2004242838A priority patent/AU2004242838A1/en
Priority to JP2006529917A priority patent/JP2007505152A/ja
Priority to KR1020057022409A priority patent/KR20060012316A/ko
Priority to CA002527354A priority patent/CA2527354A1/en
Priority to MXPA05012826A priority patent/MXPA05012826A/es
Priority to EP04739354A priority patent/EP1638914A2/en
Priority to CNA2004800146347A priority patent/CN1795158A/zh
Priority to RU2005136984/04A priority patent/RU2005136984A/ru
Priority to DE602004010100T priority patent/DE602004010100T2/de
Publication of ITMI20031098A1 publication Critical patent/ITMI20031098A1/it
Priority to US10/558,403 priority patent/US20070010507A1/en
Priority to EC2005006190A priority patent/ECSP056190A/es
Priority to IL172213A priority patent/IL172213A0/en
Priority to NO20056042A priority patent/NO20056042L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/733—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having two rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT001098A 2003-05-30 2003-05-30 Composti utili nella terapia del morbo di alzheimer e formulazioni che li contengono ITMI20031098A1 (it)

Priority Applications (16)

Application Number Priority Date Filing Date Title
IT001098A ITMI20031098A1 (it) 2003-05-30 2003-05-30 Composti utili nella terapia del morbo di alzheimer e formulazioni che li contengono
RU2005136984/04A RU2005136984A (ru) 2003-05-30 2004-05-26 Соединения, эффективные при лечении болезни альцгеймера, и их содержащие композиции
CA002527354A CA2527354A1 (en) 2003-05-30 2004-05-26 Compounds useful in the therapy of alzheimer`s disease and formulations containing them
EP04739354A EP1638914A2 (en) 2003-05-30 2004-05-26 Compounds useful in the therapy of alzheimer's disease and formulations containing them
AU2004242838A AU2004242838A1 (en) 2003-05-30 2004-05-26 Compounds useful in the therapy of Alzheimer's disease and formulations containing them
JP2006529917A JP2007505152A (ja) 2003-05-30 2004-05-26 アルツハイマー病の治療に有効な化合物およびそれら化合物を含む製剤
KR1020057022409A KR20060012316A (ko) 2003-05-30 2004-05-26 알츠하이머병의 치료에 유용한 화합물과 그것들을 함유한제형
PCT/EP2004/005644 WO2004106275A2 (en) 2003-05-30 2004-05-26 Compounds useful in the therapy of alzheimer’s disease and formulations containing them
MXPA05012826A MXPA05012826A (es) 2003-05-30 2004-05-26 Compuestos utiles en la terapia de la enfermedad de alzheimer y formulaciones que los contienen.
BRPI0410703-9A BRPI0410703A (pt) 2003-05-30 2004-05-26 compostos úteis na terapia da doença de alzheimer e formulações contendo os mesmos
CNA2004800146347A CN1795158A (zh) 2003-05-30 2004-05-26 可用于治疗阿尔茨海默病的化合物和含有它们的制剂
DE602004010100T DE602004010100T2 (de) 2003-05-30 2004-05-28 Durch coazervation hergestellte mikrokapseln mit einem wirkstoff in ethylcellulose als hüllpolymer
US10/558,403 US20070010507A1 (en) 2003-05-30 2005-05-26 Compounds useful in the therapy of alzheimer's disease and formulations containing them
EC2005006190A ECSP056190A (es) 2003-05-30 2005-11-28 Compuestos utiles en la terapia de la enfermedad de alzheimer y formulaciones que los contienen
IL172213A IL172213A0 (en) 2003-05-30 2005-11-28 Compounds useful in the therapy of alzheimer's disease and formulations containing them
NO20056042A NO20056042L (no) 2003-05-30 2005-12-19 Forbindelser som er anvendelige til behandling av Alzheimers sykdom samt formuleringer inneholdende disse

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001098A ITMI20031098A1 (it) 2003-05-30 2003-05-30 Composti utili nella terapia del morbo di alzheimer e formulazioni che li contengono

Publications (2)

Publication Number Publication Date
ITMI20031098A0 true ITMI20031098A0 (it) 2003-05-30
ITMI20031098A1 ITMI20031098A1 (it) 2004-11-30

Family

ID=30131121

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001098A ITMI20031098A1 (it) 2003-05-30 2003-05-30 Composti utili nella terapia del morbo di alzheimer e formulazioni che li contengono

Country Status (16)

Country Link
US (1) US20070010507A1 (it)
EP (1) EP1638914A2 (it)
JP (1) JP2007505152A (it)
KR (1) KR20060012316A (it)
CN (1) CN1795158A (it)
AU (1) AU2004242838A1 (it)
BR (1) BRPI0410703A (it)
CA (1) CA2527354A1 (it)
DE (1) DE602004010100T2 (it)
EC (1) ECSP056190A (it)
IL (1) IL172213A0 (it)
IT (1) ITMI20031098A1 (it)
MX (1) MXPA05012826A (it)
NO (1) NO20056042L (it)
RU (1) RU2005136984A (it)
WO (1) WO2004106275A2 (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060287554A1 (en) * 2005-06-21 2006-12-21 Madsen Kevin K Process for producing inorganic salts of hop acids
US20070104771A1 (en) * 2005-09-23 2007-05-10 Jay Audett Transdermal galantamine delivery system
EP2236160A3 (en) * 2009-03-31 2011-12-14 Sanovel Ilac Sanayi ve Ticaret A.S. Modified release dimebolin formulations
BR112012007557A2 (pt) * 2009-10-02 2017-05-02 Blanchette Rockefeller Neurosciences Inst alterações anormais de processamento de isozimas de pkc em células periféricas da doença de alzheimer
DE102010024105A1 (de) 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
CN108135872A (zh) * 2015-07-31 2018-06-08 约翰霍普金斯大学 用于治疗认知缺陷的谷氨酰胺拮抗剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE253033T1 (de) * 1998-02-13 2003-11-15 Schwabe Willmar Gmbh & Co Stabile hyperforin-salze, verfahren zu ihrer herstellung und verwendung zur therapie der alzheimerschen krankheit
AU3738700A (en) * 1999-03-15 2000-10-04 Shaman Pharmaceuticals, Inc. Stabilized bicyclo(3.3.1)nonenes and methods of use
KR20040054738A (ko) * 2001-10-26 2004-06-25 메타프로테오믹스, 엘엘씨 시클로옥시게나제-2의 발현 및/또는 활성의 상승 억제를나타내는 쿠르쿠미노이드 조성물

Also Published As

Publication number Publication date
CN1795158A (zh) 2006-06-28
BRPI0410703A (pt) 2006-06-13
CA2527354A1 (en) 2004-12-09
RU2005136984A (ru) 2006-03-27
WO2004106275A2 (en) 2004-12-09
DE602004010100D1 (de) 2007-12-27
KR20060012316A (ko) 2006-02-07
IL172213A0 (en) 2009-02-11
NO20056042L (no) 2005-12-19
DE602004010100T2 (de) 2008-09-18
EP1638914A2 (en) 2006-03-29
JP2007505152A (ja) 2007-03-08
ITMI20031098A1 (it) 2004-11-30
ECSP056190A (es) 2006-08-30
WO2004106275A3 (en) 2005-03-17
US20070010507A1 (en) 2007-01-11
MXPA05012826A (es) 2006-02-13
AU2004242838A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
CY2015025I2 (el) Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
DK1480615T3 (da) Superfin formoterolformulering
ES2414872T8 (es) Terapia combinada para la prevención o tratamiento de la enfermedad de Alzheimer y kit correspondiente
CY2014031I2 (el) Τροποποιημενα 2’ και 3’-νουκλεοζιτικα προφαρμακα για θεραπεια μολυνσεων απο flaviviridae
PT1446122E (pt) Utilizacao de flibanserina no tratamento de disturbios de desejo sexual
HK1091813A1 (en) 2,4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
DK1392287T3 (da) Anvendelse af substituerede azetidinonderivater i behandlingen af Alzheimers sygdom
ITMI20001732A0 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
HK1077534A1 (en) Use of n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2- yl]phenyl)pyridine-3-sulphonamide in the treatment of cancer
CY2013031I1 (el) Χρηση διϋδροϊμιδαζολονων για την αγωγη της επιληψιας στους σκυλους
AU2002335794A1 (en) Allylamides useful in the treatment of alzheimer's disease
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
ITMI20031311A0 (it) Formulazioni per il trattamento di disturbi artrosici
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IL172213A0 (en) Compounds useful in the therapy of alzheimer's disease and formulations containing them
ITMI20010957A0 (it) Derivati dell'aoe-emodina e loro impiego nel trattamento di patologieneoplastiche
AU2003238046A1 (en) Substituted 3- and 4- aminomethylpiperidines for use as beta-secretase in the treatment of alzheimer's disease
ITMI20021866A1 (it) Preparazione farmaceutica in forma colloidale utile nella cura delle affezioni cutanee.
FR2859627B1 (fr) Composition cosmetique sous forme d'emulsion e/h
ITMI20031806A1 (it) Argille organofiliche e loro impiego nella preparazione di materiali nanocompositi.
AU2003248893A8 (en) Compositions and methods for the treatment of parkinson's disease and tardive dyskinesias
AU2003286530A8 (en) Substituted peptides useful in the treatment of alzheimer's disease
ITMI20020347A1 (it) Complessi tris-pirazolil borati di nichel e loro impiego nella omoco e ter-polimeririzzazione di alfa-olefine
ITRM20030213A1 (it) Composizione farmaceutica per l'uso nella cura delle